![](/img/cover-not-exists.png)
Clinical Characteristics and Disease Course in Patients Treated With Efalizumab Following Suspension of Marketing Authorization by the European Medicines Agency: A Multicenter Observational Study
L. Morell, J.M. Carrascosa, C. Ferrándiz, M. García-Bustinduy, E. Fonseca, G. Carretero, E. Daudén, S.E. Marrón, J.L. López-Estebaranz, M. Ferrán, M. Sánchez-Regaña, C. Muñoz-Santos, I. Belinchón, LuiVolume:
102
Year:
2011
Language:
english
DOI:
10.1016/s1578-2190(11)70818-6
File:
PDF, 239 KB
english, 2011